Professor Gary Lewin
Gary grew up on the Isle of Man. He studied Physiology and Pharmacology at Sheffield University, then worked on his doctoral thesis in Stephen B. McMahons lab at St. Thomas's Hospital Medical school in London. Later, in Lorne Mendell’s laboratory, Gary discovered that NGF is a critical mediator of hyperalgesia and pain. These findings formed the mechanistic basis of anti-NGF medication, like Tanezumab, that hold great promise for the treatment of inflammatory pain.
In 1993 he received a von Humboldt Fellowship to work in the department of Neurobiochemistry at the Max-Planck Institute for Psychiatry in Munich under the directorship of Professor Yves-Alain Barde. In February of 1996 he took up an appointment as an independent Group Leader at the MDC in Berlin. The projects in his lab now focus more on the molecular basis of sensory neuron mechanotransduction and sensory ion channels. In 2003 Gary obtained a joint appointment at the Charité University Medical Faculty as a full Professor.The Lewin lab uses molecular techniques to discover new molecules relevant to sensory mechanotransduction. They established the naked mole-rat as a model to understand the molecular basis of extreme physiology.
All welcome. Drinks and nibbles from 3:30pm, seminar starts, 4pm.